Abstract
Background
Positive photopatch test reactions are classified according to the International Contact Dermatitis Group. The various reaction patterns are interpreted to represent patterns such as contact allergy, photocontact allergy, photoaugmentation, and photoinhibition.
Objective
To investigate whether there are any weaknesses in the interpretation of reaction patterns.
Materials & Methods
A dermatitis patient with photoallergic contact dermatitis due to ketoprofen was photopatch tested with serial dilutions of ketoprofen in ethanol. The reaction patterns for the various concentrations were used as a basis for discussion on weaknesses regarding the present interpretations of positive photopatch test reactions.
Results
The reaction patterns to the ketoprofen photopatch at various concentrations were interpreted as (i) contact allergy, (ii) contact allergy with photoaugmentation, (iii) contact allergy and photocontact allergy, and (iv) photocontact allergy.
Conclusion
The present interpretation of positive photopatch test reactions is unreliable and therefore insufficient regarding appropriate advice for patients.
Similar content being viewed by others
References
Bruze M. What is a relevant contact allergy? Contact Dermatitis 1990; 23: 224–5.
Thune P, Jansén C, Wennersten G, et al. The Scandinavian multicenter photopatch study 1980–1985: final report. Photodermatol 1988; 5: 261–9.
Bruynzeel DP, Ferguson J, Andersen K, et al. European Taskforce for Photopatch Testing. Photopatch testing: a consensus methodology for Europe. J Eur Acad Dermatol Venereol 2004; 18: 679–82.
Bryden AM, Moseley H, Ibbotson SH, et al. Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol 2006; 155: 73747.
Pigatto PD, Guzzi G, Schena D, et al. Photopatch tests: an Italian multicentre study from 2004 to 2006. Contact Dermatitis 2008; 59: 103–8.
Bylaite M, Grigaitiene J, Lapinskaite GS. Photodermatoses: classification, evaluation and management. Br J Dermatol 2009; 161: 61–8.
European Multicentre Photopatch Test Study (EMCPPTS) Task-force. A European multicentre photopatch test study. Br J Dermatol 2012; 166: 1002–9.
Goncalo M, Ferguson J, Bonevalle A, et al. Photopatch testing: recommendations for a European photopatch test baseline series. Contact Dermatitis 2013; 68: 23943.
Goncalo M. In: Lepoittevin JP., Frosch P. (eds) Contact Dermatitis. Springer, Cham.https://doi.org/10.1007/978-3-319-72451-5_29-1
Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing — recommendations on best practice. Contact Dermatitis 2015; 73: 195–221.
Fregert S. Manual of Contact Dermatitis, 2nd edition. Munksgaard Copenhagen, 1981.
Isaksson M, Gruvberger B, Frick-Engfeldt M, Bruze M. Which test chambers should be used for acetone, ethanol, and water solutions when patch testing? Contact Dermatitis 2007; 57: 134–6.
Beattie PE, Traynor NJ, Woods JA, et al. Can a positive photopatch test be elicited by subclinical irritancy or allergy plus suberythemal UV exposure? Contact Dermatitis 2004; 51: 235–40.
Björk AK, Bruze M, Engfeldt M, et al. The reactivity of the back revisited. Are there differences in reactivity in different parts of the back? Contact Dermatitis 2017; 76: 19–26.
Engfeldt M, Hagvall L, Isaksson M, et al. Patch testing with hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) — a multicentre study of the Swedish Contact Dermatitis Research Group. Contact Dermatitis 2017; 76: 34–9.
Frick-Engfeldt M, Gruvberger B, Isaksson M, et al. Comparison of three different techniques for application of water solutions to Finn Chambers®. Contact Dermatitis 2010; 63: 284–8.
Hasan T, Jansen CT. Photopatch test reactivity: effect of photoallergen concentration and UVA dosaging. Contact Dermatitis 1996; 34: 383–6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
Financial support: none.
About this article
Cite this article
Bruze, M. Thoughts on the interpretation of positive photopatch test reactions. Eur J Dermatol 30, 541–544 (2020). https://doi.org/10.1684/ejd.2020.3877
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2020.3877